[Oestroprogestogen interference on some haematochemical parameters: glycaemia, lipid metabolism and hepatic functionality (author's transl)].

The collateral effects of 2 oral contraceptives (OCs) (0.05 mg ethinyl estradiol + 0.250 mg norgestrel; 0.03 mg ethinyl estradiol + 0.125 mg norgestrel) were studied in a group of young women ages 19-26. These effects were investigated by evaluating some hemato-chemical parameters such as glycemia; lipid metabolism (triglycerides cholesterol and total lipids); and hepatic functionality (SGOT SGPT serum bilirubin alkaline phosphatase). Blood samples were taken before OC use and then during the 2nd month of suspension after 3 6 12 18 24 30 36 42 and 48 months of treatment. This research carried out over a period of 4 years found no significant variations which would necessitate cessation of treatment. (authors) (summary in ENG)